Reuters logo
3 个月前
BRIEF-Valeritas' V-Go wearable insulin delivery device results in significant reductions in A1C
2017年5月22日 / 中午12点11分 / 3 个月前

BRIEF-Valeritas' V-Go wearable insulin delivery device results in significant reductions in A1C

May 22 (Reuters) - Valeritas Holdings Inc:

* Valeritas' V-Go wearable insulin delivery device results in significant reductions in A1C, insulin requirements and cost reductions in patients with diabetes Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below